Cystatin C, an established sensitive marker of glomerular filtration [1], has also been widely recognized as a strong predictor of cardiovascular disease (CVD) [2–5], this even in populations within apparently normal ranges of renal function [6, 7]. Here, CST3 is linked to cardiovascular disorder.